Isec Healthcare Ltd · SGX:40T
Isec Healthcare — Shareholder Meeting (April 2022)
29 slides from Isec Healthcare's shareholder meeting presentation, Apr 22, 2022
Slide 1: Seeing the Potential - 8th Annual General Meeting
ISEC Healthcare Ltd. (“ISEC Healthcare” or the “Company”) SEEING THE POTENTIAL 8th Annual General Meeting 22nd April 2022 Page 0
Slide 2: Sponsor statement
This announcement has been reviewed by the Company’s sponsor, PrimePartners Corporate Finance Pte. Ltd. (the “Sponsor”). It has not been examined or approved by the Singapore Exchange Securities Trading Limited (the “Exchange”) and the Exchange assumes no responsibility for the contents of this docu
Slide 3: Disclaimer
Disclaimer This presentation contains certain financial information and results of operation, and may also contain certain projections, plans, strategies and objectives of the Company which are not statements of historical fact but may constitute “forward-looking statements” that reflect the Company
Slide 4: Table of Content
Table of Content Business Overview Financial Highlights Corporate Developments Outlook Page 3
Slide 5: Business Overview
Business Overview Page 4
Slide 6: Our Presence
Business Overview Our Presence Number of Eye Care Centres (as at 22nd April 2022): Penang Malaysia – 5 (N1) Singapore – 1 (N2) Sibu Myanmar – 1 Kuala Lumpur N1 – ISEC Sdn. Bhd. had on 6 April 2022 entered into a share purchase and subscription agreement to expand ISEC presence into Perak, Malacca Ma
Slide 7: Our Competitive Strengths
Business Overview Our Competitive Strengths 1 Highly qualified and experienced specialist doctors 6 Business model aligns the 2 interests of our High quality and specialist doctors with comprehensive range of our Group and eye care services Shareholders 5 Ability to replicate our 3 Well positioned t
Slide 8: Financial Highlights
Financial Highlights Page 7
Slide 9: Revenue – 5 Years (2017 – 2021)
Financial Highlights Revenue – 5 Years (2017 – 2021) S$’Million S$3.4 mil (9%) S$2.5 mil (6%) S$4.2 mil (11%) 42.9 S$6.6 mil (15%) 40.4 40.5 45.0 37.0 36.3 40.0 35.0 30.0 25.0 20.0 15.0 10.0 5.0 - 2017 2018 2019 2020 2021 The Group’s revenue increased by 11%, from S$36.3 million in FY2020 to S$40.5
Slide 10: Revenue Breakdown – By Business Segment
Financial Highlights Revenue Breakdown – By Business Segment Revenue (S$’Million) and Contribution Percentage by Business Segment S$’Million 3.7 , 9% 40.5 3.5 , 10% 2021 3.7 36.8 Up S$4.2mil (11%) 36.3 2020 3.5 32.8 , 90% 32.8 Outer Circle: FY2021 Inner Circle: FY2020 - 5.0 10.0 15.0 20.0 25.0 30.0
Slide 11: Revenue Breakdown – By Geographical Segment
Financial Highlights Revenue Breakdown – By Geographical Segment Revenue (S$’Million) and Contribution Percentage by Geographical Segment S$’Million 1.0 , 3% 9.0 , 22% 40.5 1.0 0.4 , 1% 2021 30.5 Up 7.3 , 20% 9.0 S$4.2mil (11%) 36.3 2020 0.4 28.6 Outer Circle: FY2021 28.6 , 79% 7.3 Inner Circle: FY2
Slide 12: Profit attributable to owners of Company – 5 Years
Financial Highlights Profit attributable to owners of Company – 5 Years (2017 – 2021) Net Profit attributable to owners of Company (S$’Million) Earnings Per Share (Singapore Cents) S$’Million Singapore Cents 7.9 8.4 7.5 S$2.2 mil (47%) 1.63 9.0 6.9 1.80 1.53 0.39 cents (46%) 1.41 8.0 1.60 1.25 7.0 1
Slide 13: Net Asset Value attributable to owners – 5 Years
Financial Highlights Net Asset Value attributable to owners of Company – 5 Years (2017 – 2021) Net Asset Value attributable to owners of Company Net Asset Value Per Share (S$) (S$’Million) S$’Million S$2.3 mil (3%) S$ S$0.01 (8%) 71.1 0.13 0.13 0.13 0.12 80.0 66.1 66.9 68.8 0.12 63.6 0.13 70.0 0.12
Slide 14: Dividends
Financial Highlights Dividends S$’Million 16.0 180.0% 14.0 160.0% 140.0% 12.0 120.0% 10.0 100.0% 8.0 80.0% 6.0 60.0% 4.0 40.0% 2.0 20.0% - 0.0% 2017 2018 2019 2020 2021 Dividends Paid/Payable 6.2 13.4 4.3 4.4 5.8 (N1) % of Profit Attributable to owners of Company 78.5% 159.5% 57.3% 93.6% 84.1% Divid
Slide 15: Corporate Developments
Corporate Developments Page 14
Slide 16: Corporate Developments 2021: COVID-19 Vaccination Centres
Corporate Developments 2021 1) 15 June 2021 – Participation of Malaysia Clinics in the Private COVID-19 Vaccination Centres in Kuala Lumpur and Melaka for the National COVID-19 Immunisation Programme • In response to Malaysia’s Public-Private collaboration initiative on National COVID-19 Immunisatio
Slide 17: Proposed Acquisition of Bangsar South Medical Centre Floor
Corporate Developments 2021 2) 12 August 2021 – Entry into a Letter of Offer for the Proposed Acquisition of One Floor with a Total Floor Area Measuring Approximately 60,000 to 70,000 Square Feet in a Commercial Building in Wilayah Persekutuan Kuala Lumpur Malaysia to be Constructed and Known as Ban
Slide 18: Proposed Acquisition of Bangsar South Medical Centre (cont'd)
Corporate Developments 2021 2) 12 August 2021 – Entry into a Letter of Offer for the Proposed Acquisition of One Floor with a Total Floor Area Measuring Approximately 60,000 to 70,000 Square Feet in a Commercial Building in Wilayah Persekutuan Kuala Lumpur Malaysia to be Constructed and Known as Ban
Slide 19: Incorporation of an Indirect Wholly-Owned Subsidiary
Corporate Developments 2021 3) 13 December 2021 – Incorporation of an Indirect Wholly-Owned Subsidiary • Southern Specialist Eye Centre Sdn. Bhd. (“SSEC”), an indirect wholly-owned subsidiary of the Company, has on 13 December 2021 incorporated a wholly-owned subsidiary in Malaysia (the “New Entity”
Slide 20: April 2022 Proposed Transaction: Acquisition Summary
Corporate Developments 2022 1) 7 April 2022 – Proposed Transaction in Relation to: (i) The Acquisition of 100.0% of the Issued and Paid-Up Capital of Each of (1) IE Centre Sdn. Bhd., and (2) Kampar Eye Sdn. Bhd.; and (ii) The Subscription of Ordinary Shares in Each of (1) ME Centre Sdn Bhd, (2) TE C
Slide 21: Proposed Transaction: Acquisition Summary (cont'd)
Corporate Developments 2022 1) 7 April 2022 – Proposed Transaction in Relation to: (i) The Acquisition of 100.0% of the Issued and Paid-Up Capital of Each of (1) IE Centre Sdn. Bhd., and (2) Kampar Eye Sdn. Bhd.; and (ii) The Subscription of Ordinary Shares in Each of (1) ME Centre Sdn Bhd, (2) TE C
Slide 22: Proposed Transaction: Acquisition Summary (cont'd)
Corporate Developments 2022 1) 7 April 2022 – Proposed Transaction in Relation to: (i) The Acquisition of 100.0% of the Issued and Paid-Up Capital of Each of (1) IE Centre Sdn. Bhd., and (2) Kampar Eye Sdn. Bhd.; and (ii) The Subscription of Ordinary Shares in Each of (1) ME Centre Sdn Bhd, (2) TE C
Slide 23: Proposed Transaction: Summary of Proposed Subscription
Corporate Developments 2022 1) 7 April 2022 – Proposed Transaction in Relation to: (i) The Acquisition of 100.0% of the Issued and Paid-Up Capital of Each of (1) IE Centre Sdn. Bhd., and (2) Kampar Eye Sdn. Bhd.; and (ii) The Subscription of Ordinary Shares in Each of (1) ME Centre Sdn Bhd, (2) TE C
Slide 24: Proposed Transaction: Subscription (cont'd)
Corporate Developments 2022 1) 7 April 2022 – Proposed Transaction in Relation to: (i) The Acquisition of 100.0% of the Issued and Paid-Up Capital of Each of (1) IE Centre Sdn. Bhd., and (2) Kampar Eye Sdn. Bhd.; and (ii) The Subscription of Ordinary Shares in Each of (1) ME Centre Sdn Bhd, (2) TE C
Slide 25: Rationale for the Proposed Transaction
Corporate Developments 2022 1) 7 April 2022 – Proposed Transaction in Relation to: (i) The Acquisition of 100.0% of the Issued and Paid-Up Capital of Each of (1) IE Centre Sdn. Bhd., and (2) Kampar Eye Sdn. Bhd.; and (ii) The Subscription of Ordinary Shares in Each of (1) ME Centre Sdn Bhd, (2) TE C
Slide 26: Outlook
Outlook Page 25
Slide 27: Outlook: COVID-19 Outbreak
Outlook Coronavirus 2019 (“COVID-19”) Outbreak • For the current year ending 31 December 2022, while we are optimistic that our performance will improve with gradual resumption of travel, business and lifestyle activities globally, we are also mindful that the COVID-19 situation remains fluid all ov
Slide 28: Outlook: Political Situation in Myanmar
Outlook Political Situation in Myanmar • Myanmar’s military announced the extension of the state of emergency measure, which was due to end on 31 January 2022, for another six months. The military has been facing persistent opposition from anti-coup protesters. In the country’s largest city of Yango
Slide 29: Thank You
Thank You Page 28